Floatz logo

METRONIDAZOLE

Autoimmune Hepatitis

Cliniques universitaires Saint-Luc- Université Catholique de LouvainSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Autoimmune Hepatitis cohort.

Asset / SponsorPhaseRating
URSODEOXYCHOLIC ACID
West China Hospital
Phase 4BB
Azathioprine
Xiaoli Fan
Phase 4BB
CYCLOSPORIN A
West China Hospital
Phase 4B
Jkb-122
TaiwanJ Pharmaceuticals Co., Ltd
Phase 2CCC
Orbcel-C
University of Birmingham
Phase 1/2CCC
Siplizumab
Elizabeth C. Verna
Phase 1C
Budesonide
Mayo Clinic
N/AD

Same molecule, other indications

METRONIDAZOLE is also rated in:

Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →
colorectal neoplasmDormant
BB
Indicative ·
69 / 100
View asset →
Surgery--ComplicationsDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →